New Jersey Law Journal | Analysis
By Barry J. Schindler and Ryan M. Schneer | February 12, 2020
Practical tips addressing IP-related issues that arise for companies with multiple subsidiaries in the U.S. and/or abroad.
New Jersey Law Journal | Analysis
By Robert M. Brush | September 13, 2019
How Congress and the USPTO are working to simplify the analysis of what qualifies as an invention that can be patented.
New Jersey Law Journal | Analysis
By James T. Corcoran | September 12, 2019
Patent practitioners, especially those in the pharmaceutical industry, should be mindful of taking any action that might result in applicant delay, especially in the context of supplemental replies and information disclosure statements.
New Jersey Law Journal | Analysis
By James J. DeCarlo and Vishesh Narayen | September 5, 2019
The court's unanimous and precedential decision clarifies that issued U.S. patents should indeed be accorded a presumption of eligibility.
New Jersey Law Journal | Analysis
By Jonathan D. Bick | August 16, 2019
Internet inventions come in four major categories, each with a different way of best protecting it.
New Jersey Law Journal | Analysis
By David S. Gold | June 21, 2019
Branding is not a new concept, nor are the various intellectual property laws that protect brands. What is new to most is how this burgeoning industry can take advantage of those laws within the context of state and federal restrictions.
New Jersey Law Journal | Analysis
By James J. DeCarlo and George David Zalepa | May 10, 2019
Once again, the post-'Alice' world of software patents gets turned on a new axis as the USPTO and the Court of Appeals for the Federal Circuit fail to agree on how to determine patentable subject matter.
New Jersey Law Journal | Analysis
By Barry J. Schindler and Laurin T. Buettner | February 15, 2019
How to guard your patents abroad, even though U.S. patent protection is not extraterritorial.
By Charles Toutant | September 19, 2018
The ruling came in a suit filed on behalf of a putative class made up of labor unions, insurance companies and other indirect purchasers who say they are charged more for Effexor XR due to various anti-competitive tactics by Wyeth, which is a subsidiary of Pfizer, and Teva.
New Jersey Law Journal | Analysis
By Barry J. Schindler, James J. DeCarlo and Smit Kapadia | September 14, 2018
On Aug. 10, 2018, the USPTO released its first update to the Trial Practice Guide since its initial publication in August of 2012. Practitioners appearing before the Patent Trial and Appeal Board should follow these guidelines as they offer new tools and highlight important caveats.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS